Solvent effects on structural and thermochemical properties of p53 tumor-suppressor gene: a molecular modeling

Shiva Irani1, Seyed Mohammad Atyabi, Houri Mivehchi

  • 1Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.

Insights

Computational chemistry reveals how solvents impact p53 protein mutation hotspots. Understanding these solvent effects on GAT and CUA structures aids in designing drugs to restore wild-type p53 conformation.

Area of Science:

  • Computational chemistry
  • Molecular dynamics
  • Biophysics

Background:

  • p53 tumor-suppressor protein regulates cell growth; mutations often occur in the DNA-binding domain.
  • Targeting p53 mutations with drugs is a promising strategy for cancer therapy.
  • Understanding solvent effects on mutation sites is crucial for drug design.

Purpose of the Study:

  • Investigate solvent-induced effects on p53 mutation hotspots (GAT).
  • Determine optimal solvent conditions for mutation site stability.
  • Compare hydration energies of GAT and CUA using different computational models.

Main Methods:

  • Employed Hartree-Fock calculations to study solvent effects.
  • Analyzed thermochemical parameters, relative energies, and NMR shielding tensors.
  • Utilized polarized continuum models and clustered water molecule approaches for hydration energy calculations.

Main Results:

  • Solvent media significantly affect GAT's thermochemical parameters and relative energies.
  • Clustered water molecules around GAT and CUA hotspots are energetically favored.
  • Computational models provide insights into mutation processes and drug design.

Conclusions:

  • Solvent choice influences the stability of p53 mutation hotspots.
  • Computational methods offer valuable insights into biochemical mutations.
  • Findings support the development of targeted therapies for p53-related diseases.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...